Consolidated Statement Of Income

Carna Biosciences, Inc. - Filing #7613644

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Consolidated statement of income
Statement of income
Net sales
1,931,718,000 JPY
2,017,529,000 JPY
JPY
2,017,529,000 JPY
1,128,000,000 JPY
889,529,000 JPY
1,133,346,000 JPY
1,080,321,000 JPY
1,042,960,000 JPY
1,133,346,000 JPY
JPY
53,025,000 JPY
Cost of sales
130,504,000 JPY
135,387,000 JPY
192,149,000 JPY
176,385,000 JPY
Operating expenses
Selling, general and administrative expenses
2,359,421,000 JPY
2,413,277,000 JPY
1,998,264,000 JPY
1,942,029,000 JPY
Depreciation
4,423,000 JPY
2,775,000 JPY
Operating expenses
Operating expenses
Operating expenses - general
General and administrative expenses
Operating expenses
Research and development expenses
1,841,854,000 JPY
1,841,854,000 JPY
1,474,452,000 JPY
1,480,664,000 JPY
Operating profit (loss)
-558,207,000 JPY
-531,135,000 JPY
JPY
-531,135,000 JPY
-820,156,000 JPY
289,021,000 JPY
-1,057,067,000 JPY
458,741,000 JPY
-1,075,454,000 JPY
-1,057,067,000 JPY
JPY
-1,515,809,000 JPY
Ordinary profit (loss)
-548,843,000 JPY
-522,992,000 JPY
-1,077,096,000 JPY
-1,096,348,000 JPY
Net sales
Gross profit (loss)
1,801,213,000 JPY
1,882,141,000 JPY
941,196,000 JPY
866,574,000 JPY
Non-operating income
Interest income
37,000 JPY
107,000 JPY
124,000 JPY
52,000 JPY
Dividend income
399,000 JPY
399,000 JPY
389,000 JPY
389,000 JPY
Other
837,000 JPY
837,000 JPY
237,000 JPY
142,000 JPY
Non-operating income
25,536,000 JPY
24,315,000 JPY
2,749,000 JPY
2,583,000 JPY
Cost of sales
Extraordinary income
JPY
JPY
1,000,000 JPY
1,000,000 JPY
Selling, general and administrative expenses
Non-operating expenses
16,172,000 JPY
16,172,000 JPY
22,778,000 JPY
23,477,000 JPY
Interest expenses
3,769,000 JPY
3,925,000 JPY
7,373,000 JPY
7,152,000 JPY
Share issuance costs
3,766,000 JPY
3,766,000 JPY
4,373,000 JPY
4,373,000 JPY
Extraordinary losses
9,507,000 JPY
9,507,000 JPY
26,390,000 JPY
26,390,000 JPY
Impairment losses
9,507,000 JPY
9,507,000 JPY
9,507,000 JPY
JPY
JPY
9,507,000 JPY
JPY
26,390,000 JPY
JPY
26,390,000 JPY
JPY
26,390,000 JPY
JPY
26,390,000 JPY
Non-operating expenses
Other
1,346,000 JPY
1,190,000 JPY
14,000 JPY
235,000 JPY
Profit (loss) before income taxes
-558,351,000 JPY
-532,499,000 JPY
-1,102,487,000 JPY
-1,121,738,000 JPY
Gross profit
Extraordinary income
Income taxes - current
3,880,000 JPY
7,780,000 JPY
3,015,000 JPY
2,344,000 JPY
Extraordinary losses
Income taxes - deferred
-5,805,000 JPY
-5,805,000 JPY
5,529,000 JPY
5,529,000 JPY
Income taxes
-1,925,000 JPY
1,975,000 JPY
8,545,000 JPY
7,873,000 JPY
Profit (loss)
-556,425,000 JPY
-534,474,000 JPY
-556,425,000 JPY
-556,425,000 JPY
-556,425,000 JPY
-1,111,032,000 JPY
-1,129,612,000 JPY
-1,129,612,000 JPY
-1,129,612,000 JPY
-1,129,612,000 JPY
Profit (loss) attributable to owners of parent
-534,474,000 JPY
-534,474,000 JPY
-534,474,000 JPY
-1,111,032,000 JPY
-1,111,032,000 JPY
-1,111,032,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
-652,000 JPY
376,000 JPY
Deferred gains or losses on hedges
7,754,000 JPY
-1,176,000 JPY
Foreign currency translation adjustment
16,396,000 JPY
-8,058,000 JPY
Other comprehensive income
23,498,000 JPY
-8,858,000 JPY
Comprehensive income
-510,976,000 JPY
-1,119,890,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-510,976,000 JPY
-1,119,890,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.